DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the ASTER DM HEALTHCARE LTD. (ASTERDM) share price today?

ASTER DM HEALTHCARE LTD. (ASTERDM) is trading at ₹819.9 on the NSE, up 0.96% on the day. Source: DocStoX.

What is the PE ratio of ASTER DM HEALTHCARE LTD.?

ASTER DM HEALTHCARE LTD. has a price-to-earnings (PE) ratio of 109.5 in the Healthcare sector.

What is the market capitalisation of ASTER DM HEALTHCARE LTD.?

ASTER DM HEALTHCARE LTD. has a market capitalisation of approximately ₹42,502 crore.

ASTER DM HEALTHCARE LTD.

ASTERDM·NSE·Healthcare

₹819.90▲ +7.80 (+0.96%)

Healthcare · Hospital

A steady, established business

NIFTY 500NIFTY SMALLCAP 250

Day₹812.05

₹825.60

52W₹517

₹83795%

Open

₹814.00

High

₹825.60

Low

₹812.05

Prev Close

₹812.10

Volume

5.35L

VWAP

₹819.09

Snapshot

Key fundamentals

Market Cap

₹42,502 Cr

P/E Ratio

109.47Expensive

P/B Ratio

8.96

EPS

₹7.49

Book Value

₹88.30

ROE

10.70%Average

ROCE

11.00%Decent

Dividend Yield

0.37%

Debt / Equity

0.49Moderate

Face Value

₹10.00

52W High

₹836.50

52W Low

₹516.84

Sector

Healthcare

Industry

Hospital

Avoid

None moatMedium uncertainty

Fair value estimate

₹94

▼ 88.6%downside

Trading at ₹820 — 89% above our estimate

BearFair valueBull

₹80₹94₹122

/100

Business quality — Watch the fundamentals

Growth 31Profitability 34Efficiency 8Valuation 38

Plain English

Our view

A steady, established business
Low debt relative to equity
Expensive — trades at 109× earnings

Strengths

Low debt relative to equity
Revenue compounding 16% over 3 years

Risks

Expensive — trades at 109× earnings
Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

11% ROE fading to 13% over ~3 yrs, on ₹88 book

₹86

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹122

Analyst target

No analyst coverage

—

Blended fair value₹94

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Revenue compounding 16% over 3 years

Bear case

Expensive — trades at 109× earnings
Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

109.5Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

10.7%Average

Above 15% is considered healthy for Indian equities

ROCE

11.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.49Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹42,502 Cr

P/B

8.96

EPS

₹7.49

Div Yield

0.37%

What changed

Recent changes

Foreign investors-6.7% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 109.5×

Growth

Strong

+16% rev CAGR

Profitability

Modest

10.7% ROE

Financial health

Comfortable

D/E 0.49

Momentum

N/A

No technicals

Today

Trading activity

Delivery %67.9%

Turnover₹4378.92L Cr

Trades26,030

VWAP₹819.09

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+15.8%

-11.6%

10Y

-1.2%

Profit

-3.5%

+19.1%

10Y

+48.8%

EPS

-4.2%

+20.4%

10Y

+43.7%

Profile

Pros

Company has been maintaining a healthy dividend payout of 1,560%

Watch-outs

Cons

Stock is trading at 9.16 times its book value
Company has a low return on equity of 7.23% over last 3 years.
Promoters have pledged 40.7% of their holding.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Foreign investors sold 6.65 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

40%

Promoter

Promoters

40.4%0.00

Public

21.4%+6.80

FII / FPI

10.5%-6.65

DII

27.6%+0.08

Quarterly trend

Ownership over time

Q1 FY27

Promoter40.39%

FII10.53%

DII27.65%

Public21.41%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions